Hudson Bay Capital Management LP Mirati Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Mirati Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 100,000 shares of MRTX stock, worth $0. This represents 0.06% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$0% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRTX
# of Institutions
16Shares Held
3.57MCall Options Held
0Put Options Held
36.6K-
Sawtooth Solutions, LLC3.14MShares$05.07% of portfolio
-
International Biotechnology Trust PLC London, X0216KShares$03.19% of portfolio
-
Tekla Capital Management LLC65.5KShares$00.09% of portfolio
-
Kellner Capital, LLC New York, NY41.4KShares$04.38% of portfolio
-
Brinker Capital Investments, LLC22.7KShares$00.02% of portfolio
About Mirati Therapeutics, Inc.
- Ticker MRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,609,800
- Description
- Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...